Dietary Iron Intake and Risk of Gastric Cancer

Further Publications

Five-Year Unified Risk Prediction Model for Gastric and Esophageal Cancer Based on Nationwide Health Check-Up Data in Japan: J-GESS Score

J Gastroenterol Hepatol

Watanabe K, Fukuda S, Kubota D, Yamamichi N, Takahashi Y, Watanabe Y, Adachi K, Ishimura N, Koike T, Sugawara H, Asanuma K, Abe Y, Kon T, Ihara E, Haraguchi K, Otsuka Y, Yoshimura R, Iwaya Y, Okamura T, Manabe N, Horiuchi A, Matsumoto M, Onochi K, Takahashi S, Yoshida T, Shimodaira Y, Iijima K

doi: 10.1111/jgh.70409

Colonoscopy

Individuals with polyps ≥10mm without other high-risk features have a similarly low post-colonoscopy colorectal cancer risk as those with no polyps

Endoscopy

van Roermund NS, van Leerdam ME, Spaander MCW, Dekker E, IJspeert JEG

doi: 10.1055/a-2730-6060

ColonoscopyGastrointestinal Cancer

Utility of quantitative fecal immunochemical test values for average risk colorectal cancer screening risk stratification among patients with a positive test

Am J Gastroenterol

H-E Kang J, Jensen CD, Merchant S, Selby K, Badalov JM, Corley DA, Levin TR, Lee JK

doi: 10.14309/ajg.0000000000003805

Gastrointestinal Cancer

Increased risk of young-onset pancreatic cancer among adults aged 20-39 years with overweight or obesity, but not underweight: A nationwide cohort study

Eur J Cancer

Kim HJ, Park JH, Hong JY, Han K, Shen JJ, Park JO, Park YS, Lim HY

doi: 10.1016/j.ejca.2025.116111

Helicobacter Pylori

Gastric Cancer Prevention in Taiwan: Past Achievements and Future Perspectives

Helicobacter

Chuang SL, Chu TC, Chiang TH, Chen YR, Lei WY, Chen CL, Bair MJ, Wu JY, Wu DC, O'Donnell FT, Tien HW, Chiu SY, Cheng HC, Hsu YH, Hsu TH, Hsieh PC, Lin LJ, Subeq YM, Wen SH, Chu CH, Wu MS, Lee YC

doi: 10.1111/hel.70102

Helicobacter Pylori

EUROHELICAN-Accelerating Gastric Cancer Reduction Through Helicobacter pylori Eradication

Helicobacter

Tepeš B, Bric TK, Oblak M, Završnik J, Vošner HB, Ražuka-Ebela D, Leja M, Knaze V, Park JY, Matysiak-Budnik T

doi: 10.1111/hel.70097

Gastrointestinal Cancer

Hereditary diffuse gastric cancer spectrum associated with germline CTNNA1 loss of function revealed by clinical and molecular data from 351 carrier families and over 37 000 non-carrier controls

Gut

Lobo S, Dias A, Pedro AM, Ferreira M, Pinto-Oliveira A, São José C, Herrera-Mullar J, Pinto N, Colas C, Hüneburg R, Nattermann J, Boussemart L, van Hest LP, Moreira L, Horton C, Farengo Clark D, Tinschert S, Golmard L, Spier I, López-Fernández A, Oliveira D, Svrcek M, Bourgoin P, Coulet F, Delhomelle H, Davis J, Zäncker B, Lazaro C, Guerra J, Almeida ML, Carrera S, Patiño A, Gundlach P, Laszkowska M, Strong VE, Teixeira MR, Schrader I, Steinke-Lange V, Gullo I, Sousa S, Batista M, Aretz S, Balmaña J, Aronson M, Antoniazzi AP, Palmero EI, Mansfield P, van der Kolk LE, Cats A, van Dieren JM, Castellví-Bel S, Katona B, Karam R, Pereira PS, Benusiglio PR, Oliveira C

doi: 10.1136/gutjnl-2024-334601

Gastrointestinal Cancer

World Cancer Research Fund /American Institute for Cancer Research Screener algorithm versus standard Score: Association with mortality in colorectal cancer patients

Cancer Epidemiol Biomarkers Prev

Nafría M, Wesselink E, Kampman E, van Zutphen M, van Duijnhoven FJB, Kok DE, Romaguera D, Winkels RM

doi: 10.1158/1055-9965.EPI-25-2056

Inflammatory Bowel Disease

Cancer risk with methotrexate-TNF antagonist combination therapy compared to TNF-antagonist monotherapy in IBD

Inflamm Bowel Dis

Anvari S, Wanchaitanawong W, Xiong X, Cai T, Ananthakrishnan AN

doi: 10.1093/ibd/izag143

Related content

Five-Year Unified Risk Prediction Model for Gastric and Esophageal Cancer Based on Nationwide Health Check-Up Data in Japan: J-GESS Score

Individuals with polyps ≥10mm without other high-risk features have a similarly low post-colonoscopy colorectal cancer risk as those with no polyps

Utility of quantitative fecal immunochemical test values for average risk colorectal cancer screening risk stratification among patients with a positive test

Increased risk of young-onset pancreatic cancer among adults aged 20-39 years with overweight or obesity, but not underweight: A nationwide cohort study

Gastric Cancer Prevention in Taiwan: Past Achievements and Future Perspectives

EUROHELICAN-Accelerating Gastric Cancer Reduction Through Helicobacter pylori Eradication

Hereditary diffuse gastric cancer spectrum associated with germline CTNNA1 loss of function revealed by clinical and molecular data from 351 carrier families and over 37 000 non-carrier controls

World Cancer Research Fund /American Institute for Cancer Research Screener algorithm versus standard Score: Association with mortality in colorectal cancer patients

Cancer risk with methotrexate-TNF antagonist combination therapy compared to TNF-antagonist monotherapy in IBD